Phase-II trial of oral idarubicin (4-demethoxydaunorubicin) in advanced breast cancer.

Suppr

超能文献

作者信息

Wander H E, Meyer D, Schuff-Werner P, Nagel G A

出版信息

Onkologie. 1986 Aug;9(4):236-8. doi: 10.1159/000216014.

DOI:10.1159/000216014

PMID:3531951

Abstract

摘要

相似文献

Phase-II trial of oral idarubicin (4-demethoxydaunorubicin) in advanced breast cancer.

Onkologie. 1986 Aug;9(4):236-8. doi: 10.1159/000216014.

[Phase II study of 4-demethoxydaunorubicin in metastatic breast neoplasms].

G Ital Chemioter. 1985 Jan-Apr;32(1):59-60.

Phase II evaluation of oral idarubicin (4-demethoxydaunorubicin) in patients with disseminated malignant melanoma.

Cancer Treat Rep. 1986 Jul;70(7):911-2.

Phase II study of idarubicin in advanced endometrial carcinoma.

Cancer Treat Rep. 1987 May;71(5):535-6.

A phase II study of oral weekly 4-demethoxydaunorubicin in advanced breast cancer.

Eur J Cancer Clin Oncol. 1987 Apr;23(4):391-4. doi: 10.1016/0277-5379(87)90375-0.

Oral 4-demethoxydaunorubicin (idarubicin) in bronchogenic lung cancer; phase II trial.

Invest New Drugs. 1986;4(3):275-8. doi: 10.1007/BF00179596.

Phase II study of idarubicin given orally in the treatment of anthracycline-naive advanced breast cancer patients.

Cancer Treat Rep. 1987 May;71(5):451-4.

A phase II study of idarubicin (4-demethoxydaunorubicin) in advanced myeloma.

Eur J Cancer Clin Oncol. 1988 Apr;24(4):681-4. doi: 10.1016/0277-5379(88)90299-4.

Phase II trial of 4-demethoxydaunorubicin in patients with advanced malignant melanoma.

Cancer Treat Rep. 1985 Jul-Aug;69(7-8):915-6.

Phase II trial with oral idarubicin in advanced breast cancer.

Invest New Drugs. 1986;4(1):39-42. doi: 10.1007/BF00172014.

引用本文的文献

Oral idarubicin. A review of its pharmacological properties and clinical efficacy in the treatment of haematological malignancies and advanced breast cancer.

Drugs Aging. 1997 Jul;11(1):61-86. doi: 10.2165/00002512-199711010-00006.

Oral idarubicin--an anthracycline derivative with unique properties.

Ann Hematol. 1993 Jan;66(1):33-43. doi: 10.1007/BF01737687.

Combination chemotherapy with 5-fluorouracil, oral Idarubicin, and cyclophosphamide (FIC) in metastatic breast cancer--an open phase II study.

J Cancer Res Clin Oncol. 1988;114(3):301-5. doi: 10.1007/BF00405838.

A phase II study of oral idarubicin (4-demethoxydaunorubicin) in advanced breast cancer.

Cancer Chemother Pharmacol. 1988;21(4):351-4. doi: 10.1007/BF00264204.

Idarubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the chemotherapy of cancer.

Drugs. 1991 Oct;42(4):690-719. doi: 10.2165/00003495-199142040-00010.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验